Aller au contenu principal
Accès ouvert déclaré 2026 article

Deletion of Pleiotrophin protects against high-fat diet-induced liver metabolic disease, independently of the sexual dimorphism in dietary response

0Citations signalées, ce qui n’est pas une note de qualité
5Institutions déclarées
2Pays d’affiliation déclarés

Rattachement africain : es, it. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

Abstract Obesity is a global health problem linked to the development of metabolic syndrome and comorbidities such as metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH). Pleiotrophin (PTN) is a cytokine known for its role in tissue regeneration and energy metabolism. However, its function in hepatic metabolism and its role in MASLD progression remain to be elucidated. Here, we investigated the contribution of PTN to hepatic metabolism using male and female wild-type ( Ptn +/+ ) and PTN-deficient ( Ptn −/− ) mice fed a standard or high-fat diet (HFD) for 6 months, as well as primary hepatocytes and Huh7 cells. Ptn -deletion protected both sexes against HFD-induced body weight gain, fasting hyperglycemia, hyperinsulinemia, insulin resistance and metainflammation. Furthermore, PTN deficiency prevented hepatic steatosis, reduced triacylglyceride accumulation and protected against liver fibrosis. Mechanistically, PTN deficiency was associated with increased AMPK activation, reduced ACC abundance and phosphorylation, constitutively low DGAT2 expression and altered AKT signalling. In vitro, PTN directly promoted lipid accumulation and triacylglyceride synthesis in primary hepatocytes and Huh7 cells, supporting a direct role for PTN in regulating hepatocyte lipid metabolism. Our results highlight PTN as a key modulator of hepatic lipid metabolism, systemic inflammation and extracellular matrix remodelling during obesity. These findings identify PTN as a promising therapeutic target for MASLD, MASH and related metabolic disorders, and point to a sexual dimorphism in adaptive metabolic strategies, with females demonstrating a greater degree of protection against the liver-damaging effects of diet-induced obesity.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Deletion of Pleiotrophin protects against high-fat diet-induced liver metabolic disease, independently of the sexual dimorphism in dietary response
Date Crossref
20/08/2026
Éditeur
Springer Science and Business Media LLC
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Les institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Proteoglycans and glycosaminoglycans researchLiver Disease Diagnosis and TreatmentLiver physiology and pathology

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.